NATIONAL CANCER CENTER NETWORK · CHINA
Connecting international cancer patients directly with world-leading cellular therapies (CAR-T / TCR-T), particle radiation (Proton & Heavy Ion), and robotic surgical oncology at China’s premier National Cancer Centers.
WHY CHINA FOR ONCOLOGY
For patients facing complex, refractory, or advanced tumors, China’s designated National Cancer Centers offer direct access to particle beam radiation, next-generation cellular therapies, and high-volume surgical oncology — guided by multidisciplinary tumor boards (MDT).
CAR-T / TCR-T cellular therapies, proton & carbon ion radiation, and BNCT are approved or in clinical trials in China — some unavailable in the patient’s home country.
China’s tertiary hospitals rank among the world’s highest in oncology volume. Chief surgeons perform hundreds of procedures annually — a density of experience few institutions can match.
At comparable technology levels, total treatment costs are typically 30%-50% of US / Europe and 50%-60% of Russian private hospitals — with transparent pricing and no hidden markups.
Skip 6-12 month waiting lists at home. From medical record submission to specialist consultation in as fast as 3-5 working days, with prioritized admission scheduling.
EXPERTISE DIRECTORY
Search chief oncologists’ credentials and experience, partner hospitals’ authority and accreditation, and the maturity and indications of advanced cancer technologies — filtered by cancer type.
24 results found
National Cancer Center / CAMS Cancer Hospital
Guangdong Provincial People’s Hospital / Guangdong Lung Cancer Institute
Sun Yat-sen University Cancer Center
Peking University Cancer Hospital, GI Oncology
Fudan University Shanghai Cancer Center, Breast Surgery
Peking University Cancer Hospital, Lymphoma
Zhongshan Hospital, Fudan University — Liver Cancer Surgery
Fifth Medical Center of PLA General Hospital, Breast Oncology
Peking University Cancer Hospital, Melanoma & Sarcoma Unit
National Cancer Center / CAMS Cancer Hospital, Medical Oncology
ADVANCED THERAPIES
Targeting complex, advanced and refractory solid and hematological tumors — from dual-beam carbon ion irradiation to target-specific CAR-T infusions and minimally invasive robotic surgery.
MADE IN CHINA · ONCOLOGY
From world-first imaging systems to FDA-approved homegrown drugs, China’s oncology capability has become a new choice for patients worldwide.
World-first innovation alongside global flagships
The world’s first total-body PET-CT by United Imaging — about 40x higher sensitivity with as little as 1/40 the tracer dose for whole-body imaging.
The world’s first whole-body ultra-high-field 5.0T MRI, enabling earlier tumor detection and sharper radiotherapy targeting.
Siemens dual-modality system at Shanghai Proton and Heavy Ion Center — the world’s first heavy-ion facility to exceed 1,000 treatments per year.
Indigenously developed by Neuboron Medical; Xiamen hosts the world’s largest single-site BNCT center with capacity for ~2,400 patients annually.
HOW IT WORKS · 4-STEP PATHWAY
A structured cross-border pathway — with a dedicated clinical coordinator following your case one-on-one at every step.
Reach out with your confirmed diagnosis and primary question — no medical files needed at this step. Your coordinator guides you in organizing pathology reports, imaging and treatment history.
Your case is matched with accredited National Cancer Centers and chief oncologists specialized in your exact diagnosis. Hospital clinicians conduct a preliminary feasibility review.
The matched department reviews your translated dossier and issues a written feasibility opinion, reference cost range and estimated inpatient duration. Optional 1-on-1 encrypted video consultation with the chief oncologist.
We coordinate the official hospital-issued medical visa invitation letter, confirm admission, and provide on-site bilingual bedside assistance, followed by structured post-discharge follow-up.
PATIENT STORIES
Verified cases documenting the full journey — from remote consultation to treatment in China and follow-up care.
In Moscow I was told chemotherapy was my only option. In China, the MDT team ran genomic testing and matched me with a newly approved targeted drug. At three months my tumor had shrunk 40% — at less than half the cost of a Russian private hospital.
Alexey, 57, Moscow
Stage IV lung adenocarcinoma · Targeted + immunotherapy · 21 days
From video consultation to surgery took just one week. The chief surgeon preserved my breast and completed intraoperative radiotherapy. I was discharged in four days. A translator stayed at my bedside — I never felt the language barrier.
Sari, 45, Jakarta
Stage II breast cancer · Breast-conserving surgery + IORT · 14 days
Doctors in Dubai recommended surgical removal, but quality of life mattered to me. Heavy ion therapy required no incision. After 28 sessions my PSA returned to normal — two years on, no sign of recurrence.
Ahmed, 63, Dubai
Prostate cancer · Heavy ion therapy · 28 days
After two failed chemotherapy lines, my doctors said no standard options remained. In China I received CD19 CAR-T — 42 days from cell collection to infusion — and my day-28 PET-CT showed complete remission. During the three days of cytokine release syndrome, my coordinator and interpreter stayed outside the ward 24/7, with Russian communication never interrupted. In the West I would have waited over six months at three times the cost.
Yerlan, 48, Almaty
Relapsed/refractory DLBCL · CD19 CAR-T · 42 days
My myeloma kept relapsing after proteasome inhibitors and CD38 antibodies. China’s BCMA CAR-T brought me to MRD-negative deep remission at less than a quarter of the US cost. From expedited medical visas and hotel arrangements during cell manufacturing, to cross-border follow-up three months after infusion, the service team anticipated every step.
Chen Mei Ling, 55, Kuala Lumpur
Relapsed/refractory multiple myeloma · BCMA CAR-T · 35 days
Hospitals in Vietnam advised immediate radiotherapy, but after the MDT review in China we used the guideline-cited approach: induction chemotherapy followed by concurrent chemoradiotherapy, with IMRT precisely sparing my salivary glands. The tumor completely regressed with far less dry mouth than expected. My records were organized in Vietnamese, Chinese and English, so my doctors back home could continue follow-up seamlessly.
Mr. Nguyen, 52, Ho Chi Minh City
Locoregionally advanced NPC · Induction chemo + chemoradiotherapy · 70 days
TRANSPARENT PRICING
Medical fees are paid directly to the hospital’s official account at official pricing. Below are reference comparisons for common treatments.
| Treatment | Reference cost in China | US / Europe reference | Typical saving |
|---|---|---|---|
| CAR-T cell therapy | ¥999K – 1.29M | $400K – 500K+ | ≈ 65% |
| Proton therapy (full course) | ¥278K – 350K | $80K – 150K | ≈ 60% |
| Robotic oncologic surgery | ¥80K – 180K | $50K – 120K | ≈ 70% |
| Targeted / immunotherapy (yearly) | ¥100K – 300K | $100K – 250K | ≈ 80% |
| MDT consultation | ¥3,000 – 8,000 | $3,000 – 10,000 | ≈ 90% |
* Reference ranges based on standard clinical pathways; formal quotation follows hospital assessment. Medical fees are paid directly to the hospital — we never handle them.
Get my personalized cost estimateFAQ
Authoritative answers on treatment eligibility, costs, visas and the care pathway
China's National Cancer Centers routinely deliver CAR-T and TCR-T cellular therapy, proton and carbon-ion (heavy ion) radiotherapy, BNCT, and da Vinci robotic surgery. CAR-T products are NMPA-approved for lymphoma and leukemia, and the Shanghai Proton and Heavy Ion Center ranks among the highest-volume particle therapy centers worldwide.
Total costs are typically 40-70% lower than in the US or Europe. For reference: CAR-T therapy is approximately CNY 1.0-1.3 million, a full proton therapy course around CNY 280,000, and robotic surgery CNY 80,000-250,000. After you submit your case, we provide a written cost range based on standard clinical pathways.
Yes. We provide full multilingual medical support in English, Russian and more: certified translation of medical records, on-site interpretation at consultations, a bilingual coordinator at your bedside during hospitalization, plus discharge summaries and remote follow-up in your language.
The standard 4-step pathway: submit your case (same day), hospital feasibility review (3-5 working days), specialist consultation and plan confirmation (within 1 week), then medical visa and admission (about 2 weeks). The full cycle typically takes 2-4 weeks.
Once your treatment plan is confirmed, the admitting hospital issues an official medical visa invitation letter. Our visa specialist helps prepare the documents and schedule the consulate appointment; issuance usually takes 5-10 working days.
No. The AI consultant provides general medical information and process guidance only — it does not constitute a diagnosis or treatment recommendation. Your personal treatment plan is formally issued by the oncology specialists of the admitting hospital after a full review of your medical records.
CASE FEASIBILITY REVIEW
Share your contact details, confirmed diagnosis and main question. No medical files needed at this stage. A clinical coordinator will contact you within 24-48 hours.
